Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANDU PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANDU PHARMA   ACTAVIS
EQUITY SHARE DATA
    SANDU PHARMA
Mar-23
ACTAVIS
Dec-18
SANDU PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs8616,117-   
Low Rs5010,811-   
Sales per share (Unadj.) Rs67.63,953.4-  
Earnings per share (Unadj.) Rs1.6-1,273.4-  
Cash flow per share (Unadj.) Rs2.1416.6-  
Dividends per share (Unadj.) Rs0.750-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs40.616,305.9-  
Shares outstanding (eoy) m9.66332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.03.4 29.6%   
Avg P/E ratio x43.3-10.6 -409.4%  
P/CF ratio (eoy) x32.332.3 100.0%  
Price / Book Value ratio x1.70.8 203.1%  
Dividend payout %47.60-   
Avg Mkt Cap Rs m6584,478,069 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m1110-   
Avg. sales/employee Rs Th077,804.7-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,060.9-  
INCOME DATA
Net Sales Rs m6531,314,899 0.0%  
Other income Rs m325,145 0.0%   
Total revenues Rs m6571,340,044 0.0%   
Gross profit Rs m2534,457 0.1%  
Depreciation Rs m5562,091 0.0%   
Interest Rs m175,877 0.0%   
Profit before tax Rs m22-578,366 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,507 0.0%   
Tax Rs m7-7,330 -0.1%   
Profit after tax Rs m15-423,530 -0.0%  
Gross profit margin %3.82.6 145.2%  
Effective tax rate %31.41.3 2,478.0%   
Net profit margin %2.3-32.2 -7.2%  
BALANCE SHEET DATA
Current assets Rs m255539,303 0.0%   
Current liabilities Rs m139477,085 0.0%   
Net working cap to sales %17.84.7 377.1%  
Current ratio x1.81.1 162.8%  
Inventory Days Days6520 330.4%  
Debtors Days Days26866 403.7%  
Net fixed assets Rs m286148,839 0.2%   
Share capital Rs m970-   
"Free" reserves Rs m2960-   
Net worth Rs m3925,423,345 0.0%   
Long term debt Rs m01,909,756 0.0%   
Total assets Rs m5428,477,923 0.0%  
Interest coverage x28.7-6.6 -433.4%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.20.2 777.9%   
Return on assets %3.0-4.1 -72.0%  
Return on equity %3.9-7.8 -49.6%  
Return on capital %5.9-4.8 -120.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m2469,764 0.0%  
From Investments Rs m5258,074 0.0%  
From Financial Activity Rs m6-806,256 -0.0%  
Net Cashflow Rs m13-78,026 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.29 Rs / USD

Compare SANDU PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SANDU PHARMA With: LASA SUPERGENERICS  FABINO LIFE   BIOFIL CHEMICALS  SOURCE NATURAL FOODS  NUTRAPLUS PR  



Today's Market

Sensex Today Ends 114 Points Higher | Metal Stocks Shine | VI Tanks 9% Sensex Today Ends 114 Points Higher | Metal Stocks Shine | VI Tanks 9%(Closing)

After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.